Page 8 of 9 – SEC Filing CUSIP No. 00847L100 SCHEDULE 13D Page 10 of 11
(c) Except as previously reported or as set forth in this Item 5(c), or otherwise herein, to the knowledge of the Reporting Persons with respect to the persons named in response to Item 5(a), none of the persons named in response to Item 5(a) has effected any transactions in the Common Stock during the past 60 days. Between August 29, 2016 and September 29, 2016, Aisling sold the following Shares set forth in the table below in open market transactions: Date Shares Sold Price Per Share August 29, 2016 5,000 $7.5353 August 30, 2016 11,200 $7.3148 August 31, 2016 6,900 $7.2367 September 1, 2016 115,198 $7.4455 September 2, 2016 9,703 $7.2754 September 6, 2016 11,777 $7.0899 September 7, 2016 7,426 $7.0908 September 8, 2016 32,796 $7.0368 September 20, 2016 3,138 $7.4115 September 21, 2016 7,777 $7.4299 September 22, 2016 4,220 $7.3040 September 23, 2016 4,364 $7.2005 September 26, 2016 32,843 $7.2271 September 27, 2016 25,253 $7.3460 September 28, 2016 6,023 $7.3006 September 29, 2016 5,000 $7.1254 September 30, 2016 19,724 $7.0121
(d) The partners of Aisling have the right to participate in the receipt of dividends from, or proceeds from the sale of, the shares of Common Stock held for the account of Aisling in accordance with their ownership interests in Aisling. (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
No material change. Item 7. Material to be Filed as Exhibits.
Exhibit 2: Fifth Amended and Restated Registration Rights Agreement, dated as of July 18, 2012, by and among the Issuer and the parties listed therein, as modified by the Amendment to Registration Rights Agreement, dated as of May 5, 2014, by and among the Issuer and the parties listed therein (incorporated herein by reference to Exhibit 4.2 to the Form S-1/A filed by the Issuer on May 9, 2014 (File No. 333-194621)). Exhibit 3: Joint Filing Agreement dated as of May 30, 2014, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (previously filed).
| CUSIP No. 00847L100 | SCHEDULE 13D | Page 10 of 11 |
(c) Except as previously reported or as set forth in this Item 5(c), or otherwise herein, to the knowledge of the Reporting Persons with respect to the persons named in response to Item 5(a), none of the persons named in response to Item 5(a) has effected any transactions in the Common Stock during the past 60 days.
Between August 29, 2016 and September 29, 2016, Aisling sold the following Shares set forth in the table below in open market transactions:
| Date | Shares Sold | Price Per Share |
| August 29, 2016 | 5,000 | $7.5353 |
| August 30, 2016 | 11,200 | $7.3148 |
| August 31, 2016 | 6,900 | $7.2367 |
| September 1, 2016 | 115,198 | $7.4455 |
| September 2, 2016 | 9,703 | $7.2754 |
| September 6, 2016 | 11,777 | $7.0899 |
| September 7, 2016 | 7,426 | $7.0908 |
| September 8, 2016 | 32,796 | $7.0368 |
| September 20, 2016 | 3,138 | $7.4115 |
| September 21, 2016 | 7,777 | $7.4299 |
| September 22, 2016 | 4,220 | $7.3040 |
| September 23, 2016 | 4,364 | $7.2005 |
| September 26, 2016 | 32,843 | $7.2271 |
| September 27, 2016 | 25,253 | $7.3460 |
| September 28, 2016 | 6,023 | $7.3006 |
| September 29, 2016 | 5,000 | $7.1254 |
| September 30, 2016 | 19,724 | $7.0121 |
(d) The partners of Aisling have the right to participate in the receipt of dividends from, or proceeds from the sale of, the shares of Common Stock held for the account of Aisling in accordance with their ownership interests in Aisling.
(e) Not applicable.
| Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. |
No material change.
| Item 7. | Material to be Filed as Exhibits. |
| Exhibit 2: | Fifth Amended and Restated Registration Rights Agreement, dated as of July 18, 2012, by and among the Issuer and the parties listed therein, as modified by the Amendment to Registration Rights Agreement, dated as of May 5, 2014, by and among the Issuer and the parties listed therein (incorporated herein by reference to Exhibit 4.2 to the Form S-1/A filed by the Issuer on May 9, 2014 (File No. 333-194621)). | |
| Exhibit 3: | Joint Filing Agreement dated as of May 30, 2014, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (previously filed). | |
Follow Agile Therapeutics Inc (NASDAQ:AGRX)
Follow Agile Therapeutics Inc (NASDAQ:AGRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
